| Bioactivity | JNJ-64264681 is a potent, orally active, selective and irreversible covalent BTK inhibitor. JNJ-64264681 exhibits good pharmacokinetic characteristics and can be used for cancer and autoimmune diseases research[1]. |
| Name | JNJ-64264681 |
| CAS | 2101524-34-7 |
| Formula | C27H30N6O3S |
| Molar Mass | 518.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mark S Tichenor, et al. Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2022 Nov 10;65(21):14326-14336. |
JNJ-64264681
CAS: 2101524-34-7 F: C27H30N6O3S W: 518.63
JNJ-64264681 is a potent, orally active, selective and irreversible covalent BTK inhibitor. JNJ-64264681 exhibits good p
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.